PAZOPANIB vs PEGFILGRASTIM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PAZOPANIB vs PEGFILGRASTIM: Safety Overview
| Metric | PAZOPANIB | PEGFILGRASTIM |
|---|---|---|
| Total FAERS Reports | 21,208 | 80,974 |
| Deaths Reported | 5,612 | 2,367 |
| Death Rate | 26.5% | 2.9% |
| Hospitalizations | 4,347 | 7,050 |
| Average Patient Age | 61.2 yrs | 61.2 yrs |
| % Female Patients | 41.2% | 66.3% |
| FDA Approval Date | Apr 23, 2024 | N/A |
| Manufacturer | Golden State Medical Supply, Inc. | Sandoz Inc |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |